HO5
Transcription
HO5
How to Practice at Today’s Standard of Care OROFACIAL PAIN: Standard of Care Charles McNeill, DDS, FACD, FICD Professor Emeritus & Director Patricia A. Rudd, PT, DPT CCTT Associate Clinical Professor UCSF Center for Orofacial Pain 5. Masticatory Muscle Disorders Monday, August 31, 15 ACUTE TMD DIAGNOSES Acute TMD Mgt (Localized Musculoskeletal Disorders) Monday, August 31, 15 TM Joint Pain v Masticatory Muscle Pain v AAOP TMD Dx Classification: Localized Disorders • • • • • • • ARTICULAR Devel./ Acquired Disord. Disc Disorders Inflammatory Disorders Degenerative Disorders TMJ Dislocation Ankylosis Fracture Monday, August 31, 15 AAOP TMD Dx Classification: Localized Disorders • • • • • • • ARTICULAR Devel./ Acquired Disord. Disc Disorders Inflammatory Disorders Degenerative Disorders TMJ Dislocation Ankylosis Fracture Monday, August 31, 15 • • • • • • MUSCULAR Myalgia Myofascial Pain Tendinitis Myospasm (Trismus) Myositis Myofibrotic AAOP TMD Dx Classification: Localized Disorders • • • • • • • ARTICULAR Devel./ Acquired Disord. Disc Disorders Inflammatory Disorders Degenerative Disorders TMJ Dislocation Ankylosis Fracture • • • • • • MUSCULAR Myalgia Myofascial Pain Tendinitis Myospasm (Trismus) Myositis Myofibrotic AAOP TMD Guidelines, Quintessence; 1990, 1993, 1996, 2008, 2013 Monday, August 31, 15 CURRENT CONCEPTS Re: Etiology of TMD GENDER, AGE, GENETIC (COMT Gene Variants) RISK FACTORS ๏ MUSCULAR Peripheral Sensitization • • Ischemia w Prolonged Contract. Tissue Injury Inflammation (Delayed Onset) NGF, SP, Glutamate, Histamine, CGRP ๏ Central Sensitization • • Sympath. Hemodynamic (Stress) Descending Modulatory NT Seratonin, NA, Endogen. Opiates Alstergren P et al, J Orofac Pain 2010;24:172-180 Monday, August 31, 15 CURRENT CONCEPTS Re: Etiology of TMD GENDER, AGE, GENETIC (COMT Gene Variants) RISK FACTORS ๏ MUSCULAR Peripheral Sensitization • • Ischemia w Prolonged Contract. Tissue Injury Inflammation (Delayed Onset) NGF, SP, Glutamate, Histamine, CGRP ๏ Central Sensitization • • Sympath. Hemodynamic (Stress) Descending Modulatory NT Seratonin, NA, Endogen. Opiates Systematic Reviews: (Medline, Cochrane) Low Level Evidence to Support Occlusal Factors Cause TMD Alstergren P et al, J Orofac Pain 2010;24:172-180 Monday, August 31, 15 LOCAL MYALGIA: w/o Referred Symptoms MYOFASCIAL PAIN: w Referred Symptoms v DEFINITION: Pain of Muscle Origin Affected by Affected by v PRESENTATION: Jaw Function with Replication by Provocation Testing • • • • • • Regional Dull Ache w Localized Tender Areas & Taut Bands Pain Aggravated by Function Possible Ms. Stiffness/Tightness Possible ò Opening that ñ w Assisted Stretch Pain ò w Local Anes. / Spray & Stretch Refer pain to four mandibular incisors & alveolar ridge below Monday, August 31, 15 LOCAL MYALGIA: w/o Referred Symptoms MYOFASCIAL PAIN: w Referred Symptoms v DEFINITION: Pain of Muscle Origin Affected by Affected by v PRESENTATION: Jaw Function with Replication by Provocation Testing • • • • • • Regional Dull Ache w Localized Tender Areas & Taut Bands Pain Aggravated by Function Possible Ms. Stiffness/Tightness Possible ò Opening that ñ w Assisted Stretch Pain ò w Local Anes. / Spray & Stretch Refer pain to four mandibular incisors & alveolar ridge below AAOP TMD Guidelines, Quintessence; 1990, 1993, 1996, 2008, 2013 Monday, August 31, 15 MYOFASCIAL TRIGGER POINTS Hyperirritable areas within taut bands of skeletal muscle or fascia, that give rise to characteristic referred pain, tenderness & autonomic phenomena. Crtical Evaluation QuinterJL et.al., Rheumatology .Oxford 2014 A site of secondary allodynia reflecting altered central nociceptive Latremolier A, Woolf CJ; 2009 - Travell JG, Simons DG; 1983 Monday, August 31, 15 MYOFASCIAL TRIGGER POINTS Hyperirritable areas within taut bands of skeletal muscle or fascia, that give rise to characteristic referred pain, tenderness & autonomic phenomena. Crtical Evaluation QuinterJL et.al., Rheumatology .Oxford 2014 A site of secondary allodynia reflecting altered central nociceptive Latremolier A, Woolf CJ; 2009 - Travell JG, Simons DG; 1983 Monday, August 31, 15 MYOFASCIAL TRIGGER POINTS Hyperirritable areas within taut bands of skeletal muscle or fascia, that give rise to characteristic referred pain, tenderness & autonomic phenomena. Crtical Evaluation QuinterJL et.al., Rheumatology .Oxford 2014 A site of secondary allodynia reflecting altered central nociceptive Latremolier A, Woolf CJ; 2009 - Travell JG, Simons DG; 1983 Monday, August 31, 15 MYOFASCIAL TRIGGER POINTS Hyperirritable areas within taut bands of skeletal muscle or fascia, that give rise to characteristic referred pain, tenderness & autonomic phenomena. Crtical Evaluation QuinterJL et.al., Rheumatology .Oxford 2014 A site of secondary allodynia reflecting altered central nociceptive Latremolier A, Woolf CJ; 2009 - Travell JG, Simons DG; 1983 Monday, August 31, 15 MYOFASCIAL TRIGGER POINTS Hyperirritable areas within taut bands of skeletal muscle or fascia, that give rise to characteristic referred pain, tenderness & autonomic phenomena. Crtical Evaluation QuinterJL et.al., Rheumatology .Oxford 2014 A site of secondary allodynia reflecting altered central nociceptive Latremolier A, Woolf CJ; 2009 - Travell JG, Simons DG; 1983 Monday, August 31, 15 MYOFASCIAL TRIGGER POINTS Hyperirritable areas within taut bands of skeletal muscle or fascia, that give rise to characteristic referred pain, tenderness & autonomic phenomena. Crtical Evaluation QuinterJL et.al., Rheumatology .Oxford 2014 A site of secondary allodynia reflecting altered central nociceptive Latremolier A, Woolf CJ; 2009 - Travell JG, Simons DG; 1983 Monday, August 31, 15 MYOFASCIAL TRIGGER POINTS Hyperirritable areas within taut bands of skeletal muscle or fascia, that give rise to characteristic referred pain, tenderness & autonomic phenomena. Crtical Evaluation QuinterJL et.al., Rheumatology .Oxford 2014 A site of secondary allodynia reflecting altered central nociceptive Latremolier A, Woolf CJ; 2009 - Travell JG, Simons DG; 1983 Monday, August 31, 15 MYOFASCIAL TRIGGER POINTS Hyperirritable areas within taut bands of skeletal muscle or fascia, that give rise to characteristic referred pain, tenderness & autonomic phenomena. Crtical Evaluation QuinterJL et.al., Rheumatology .Oxford 2014 A site of secondary allodynia reflecting altered central nociceptive Common manifestations of chronic pain states w assoc. allodynia/ hyperalgesia Latremolier A, Woolf CJ; 2009 - Travell JG, Simons DG; 1983 Monday, August 31, 15 MYOFASCIAL TRIGGER POINTS Hyperirritable areas within taut bands of skeletal muscle or fascia, that give rise to characteristic referred pain, tenderness & autonomic phenomena. Crtical Evaluation QuinterJL et.al., Rheumatology .Oxford 2014 A site of secondary allodynia reflecting altered central nociceptive Underlying mechanisms include peripheral and central sensitization Common manifestations of chronic pain states w assoc. allodynia/ hyperalgesia Latremolier A, Woolf CJ; 2009 - Travell JG, Simons DG; 1983 Monday, August 31, 15 PTERYGOID MUSCLES v Refer pain diffusely to mouth, below & behind the TMJ & ear v May be associated with stuffiness in ear? MEDIAL v Refer pain deeply into TMJ & maxillary sinus LATERAL Monday, August 31, 15 NOT to TEETH MYOFASCIAL TRIGGER POINTS: Referred Pain (Dermatome Pain) Rostral-Caudal Facial Dermatomes Subnucleus Caudalis Lamina 3 Sessle BJ et al: Convergence of Afferents… Pain 1986;27:219-235 R de Leeuw, GD Glasser, OFP Guidelines, 5th ed. p1-23, Quintessence, Chicago, 2013 Monday, August 31, 15 GOAL ORIENTED PLAN: Myalgia/Myofascial Pain v PAIN CONTROL: v v v v v v v INCREASE MOBILITY: ❖ Monday, August 31, 15 Patient Education Self-Mgt. (Heat, Contrast Heat & Ice, Massage, Soft Diet) Behavior Mod. (Emphasize Jaw Relaxation, Sleep Posture & Ergonomics) Meds (Muscle Relaxants or TCAs) Physical Therapy (Heat, STM, US & ES) Trigger Point Injections / Acupuncture Physical Therapy (ROM Ex’s) GOAL ORIENTED PLAN: Myalgia/Myofascial Pain v PAIN CONTROL: v v v v v v v INCREASE MOBILITY: ❖ Monday, August 31, 15 Patient Education Self-Mgt. (Heat, Contrast Heat & Ice, Massage, Soft Diet) Behavior Mod. (Emphasize Jaw Relaxation, Sleep Posture & Ergonomics) Meds (Muscle Relaxants or TCAs) Physical Therapy (Heat, STM, US & ES) Trigger Point Injections / Acupuncture Physical Therapy (ROM Ex’s) PATIENT EDUCATION v Reassure Patient Re. ↓ Morbidity of Sn & Sx v Thoroughly Explain the Dx & It’s Significance Explain Risk-Benefit Ratios of Each Management Option Including No Tx Emphasize the Need to Comply w an Individualized Self-Mgt Program Timely Management of Early Symptoms v v v Monday, August 31, 15 SYMPTOMATIC MANAGEMENT v v v v v Moist Heat Contrast Heat & Ice v Relaxes Muscles v Reduces Referred Muscle Pain Spray & Stretch Massage/Acupuncture Ergonomic Issues v Work Related Posture v Computer / Study Posture Monday, August 31, 15 SYMPTOMATIC MANAGEMENT v v v v v Moist Heat Contrast Heat & Ice v Relaxes Muscles v Reduces Referred Muscle Pain Spray & Stretch Massage/Acupuncture Ergonomic Issues v Work Related Posture v Computer / Study Posture Monday, August 31, 15 HEAT APPLICATION (20 mins.) v v Reduce Mild to Mod. Pain Decrease Muscle Tension v Improves Local Blood Flow v Relaxes Muscles v Promotes Healing v Increases Patient’s Comfort v Prepares Tissues for Movement Monday, August 31, 15 PHARMACOTHERAPY ACUTE Muscle Relaxs. v Anxiolytics v Monday, August 31, 15 CHRONIC Muscle Relaxants v Tricyclics (Pain Mgt. Dosing) v SKELETAL MUSCLE RELAXANTS v v v v v Cyclobenzaprine (Flexeril) 5-10mg 2hrs before hs v Local effect at brain stem v Potentiates Norepinephrine & Seratonin Metaxolone (Skelaxin) * 2/400mg tid/qid Tizanidine (Zanaflex) * 1mg > 8mg hs Clonazepam (Klonopin) ? 0.5-1mg tid Baclofen 5-10mg tid * (Act centrally on Alpha 2 Receptors; CNS Depressant) Monday, August 31, 15 ANXIOLYTICS: Short Term § § § Alprazolam (Xanax) 0.25-.5mg tid Lorazepam (Ativan) 2-6mg tid Diazepam (Valium) 2-10mg tid GABA Receptor Agonists; Promote Inhibitory Activity at Neural Junction Indications: Anxiety; Fast-acting Muscle Relaxation Monday, August 31, 15 TRICYCLIC ANTIDEPRESSANTS (Pain Dosing if Sleep Disturbance) v v v v Amitryptyline (Elavil) Nortriptyline (Pamelar) Doxepin (Sinequan) Desipramine (Norpramin) Titrate Dosage 10mg q 2 wks (up to 50-75mg) until âSx Inhibits NT Reuptake (Serotonin & Norepinephrine) Indications: Chron./Neuropath. Pain; Poor Sleep: Bruxism Monday, August 31, 15 TRICYCLIC ANTIDEPRESSANTS v CONTRAINDICATIONS: • • • • v ADVERSE EFFECTS: • • Monday, August 31, 15 Anticholinergic: BPH, Glaucoma, Tachycardia/Fibrillation Cardiac Disease (AV block, MI) Bipolar Disorder, Psychosis, Dementia Cognitive Impairment CNS: dizziness, drowsiness, tremor Other: Wt. gain, sweating, vivid dreams ANESTHETIC TRIGGER POINT INJECTIONS, DRY NEEDLING, BOTULINUM TOXIN-A or B (BOTOX): Limited Anesthesia at Site of Injection or Paralysis of Targeted Motor Units By Acting on Acetylcholine Receptors Nicol A Ferrante FM Clin Pain Med 2013:11 Royal Ma The Use of Botulinum Toxin in Mgt of MFP www.pain.com Monday, August 31, 15 PHYSICAL THERAPY § § § § § Patient Education Therapeutic Exercises Joint Mobilization / Manipulation Soft-tissue Mobilization Modalities § § § § Monday, August 31, 15 Heat & Ice Spray & Stretch Elect Stim. / Iontophoresis Ultrasound / Phonophoresis Myofascial Pain (Long-term Goals) v v PAIN CONTROL p.r.n.: v Self-Management (Heat, Contrast Heat & Ice, Massage) v Behavior Mod. (Emphasize Jaw Relaxation) v Oral Appliance (If Parafx. is a Sustaining Factor) IMPROVE FUNCTION: v â Meds (Flexeril p.r.n.) v Progressive Self-Mgt & Cond. Programs v Proper Head Neck Posture and Ergonomics Monday, August 31, 15 BEHAVIOR MODIFICATION § Cognitive Behavioral Intervention § Habit Awareness § § § § § § Monday, August 31, 15 Relax Face & Jaw Teeth Apart Relaxation Strategies Lifestyle Changes Coping Mechanisms Ergonomic Strategies PHYSICAL REHABILITATION v Exercises v v v v v v Postural Training v v v v Monday, August 31, 15 Proprioceptive Range of Motion (ROM) Isometric (Stabilization) Strengthening / Conditioning Cardiovascular Jaw / Tongue Head / Neck Sleep Posture Ergonomics Acute Musculoskeletal TMD/OFP Management Model Patient Education Symptomatic Care Behavior Modification Pharmacotherapy Physical Rehabilitation Oral Appliance Therapy Monday, August 31, 15 ORAL APPLIANCE INDICATIONS When Symptoms Are Are Worse on Waking Systematic Reviews: Stab Splint Therapy Compared to Other Appliances & Treatments (All TMD DX Including MFP) Monday, August 31, 15 Systematic Reviews: Stab Splint Therapy Compared to Other Appliances & Treatments (All TMD DX Including MFP) ๏ ๏ Occlusal Splints for Treatment of Bruxism Comparison of Various Splints: Hard, Soft & Non-Occl Splints; Equal Efficacy for All 3 Appliances Monday, August 31, 15 Systematic Reviews: Stab Splint Therapy Compared to Other Appliances & Treatments (All TMD DX Including MFP) ๏ ๏ Occlusal Splints for Treatment of Bruxism Comparison of Various Splints: Hard, Soft & Non-Occl Splints; Equal Efficacy for All 3 Appliances Marecdo CR et al Cochrane Database Syst Rev 2007 17:CD005514 Monday, August 31, 15 Systematic Reviews: Stab Splint Therapy Compared to Other Appliances & Treatments (All TMD DX Including MFP) ๏ ๏ Occlusal Splints for Treatment of Bruxism Comparison of Various Splints: Hard, Soft & Non-Occl Splints; Equal Efficacy for All 3 Appliances Marecdo CR et al Cochrane Database Syst Rev 2007 17:CD005514 Systematic Review of Electronic Data Search, 1966-2006 ๏ 10 RCTs in 2 Meta Analyses Comparing Hard Stabl. Appl. to Other Appl. & to Non-occl. Appl & No Tx Similiar Efficacy: to Other Appliances: Soft, Ant. Repositioning, & Ant. Bite Appl.: But Less Risk Modest Efficacy w Stab. Splint to Non-occl. Splint & No Tx Monday, August 31, 15 Systematic Reviews: Stab Splint Therapy Compared to Other Appliances & Treatments (All TMD DX Including MFP) ๏ ๏ Occlusal Splints for Treatment of Bruxism Comparison of Various Splints: Hard, Soft & Non-Occl Splints; Equal Efficacy for All 3 Appliances Marecdo CR et al Cochrane Database Syst Rev 2007 17:CD005514 Systematic Review of Electronic Data Search, 1966-2006 ๏ 10 RCTs in 2 Meta Analyses Comparing Hard Stabl. Appl. to Other Appl. & to Non-occl. Appl & No Tx Similiar Efficacy: to Other Appliances: Soft, Ant. Repositioning, & Ant. Bite Appl.: But Less Risk Modest Efficacy w Stab. Splint to Non-occl. Splint & No Tx Fricton J et. al., J Orofac Pain 2010;24:237-254 Monday, August 31, 15 Systematic Reviews: Stab Splint Therapy Compared to Other Appliances & Treatments (All TMD DX Including MFP) ๏ ๏ Occlusal Splints for Treatment of Bruxism Comparison of Various Splints: Hard, Soft & Non-Occl Splints; Equal Efficacy for All 3 Appliances Marecdo CR et al Cochrane Database Syst Rev 2007 17:CD005514 Systematic Review of Electronic Data Search, 1966-2006 ๏ 10 RCTs in 2 Meta Analyses Comparing Hard Stabl. Appl. to Other Appl. & to Non-occl. Appl & No Tx Similiar Efficacy: to Other Appliances: Soft, Ant. Repositioning, & Ant. Bite Appl.: But Less Risk Modest Efficacy w Stab. Splint to Non-occl. Splint & No Tx Fricton J et. al., J Orofac Pain 2010;24:237-254 Electronic Data Search1966-2003: 12 Relevant RCTs Comparing Stabilization Splints w AP ,BFB, Jaw Exer., Relax. Strateg., Non-occl. Appl., & No Tx No Statistically Signif. Diff. Compared to Other Active Txs; (Exercise Better for Disc Displacement) Al-Ani MZ et al. Cochrane Collaboration Cochrane Reviews 2007 List T,, Axelsson S J Oral Rehabil 2010:37:430-451 Monday, August 31, 15 SLEEP- RELATED MOVEMENT DISORDERS (Rhythmic Masticatory Muscle Activity) An Exaggerated Form of Oromotor Activity Assoc. with Sleep Microarousal which occurs 6-14 X hr (Stages 1 & 2) 10% 50% 20% v 20% ❖ ❖ Total Time Clench/Grinding 50 seconds (1% Sleep Time) Extreme Bruxism: TMD Pts = Subjects Rhythmic Mast. Ms., TMD Pts = Subjects 3-5 Non-REM to REM Cycles q 90 (70-110) min No Statistically Significant Difference of Stabilizing Appliance (Splint) Compared to Other Active Treatments;PT Exercises Better for DD Lavigne GL et.al., J Oral Rehabil 2008;35:476-494 Raphael KG et.al., JADA 2012;143:1223-1231 Al-Ani MZ et al. Cochrane Collaboration Cochrane Reviews 2007 Monday, August 31, 15 SLEEP BRUXISM: Polysomnographic (PSG) Studies ‣ Related to Autonomic & Other Brain Functions Rather than ‣ ‣ ‣ ‣ ‣ ‣ Peripheral Occlusal Sensory Mech. Brief activity in the brainstem & reticular system Stages I & II Sleep: Arousal Response Related to Periodic: Limb Move., Leg Cramps, OSA SB Higher in Children & Adolescents than Adults Tooth wear Does Not Predict SB Severity Extreme Bruxism: TMD Pts = Subjects Lavigne GL et.al., J Oral Rehabil 2008;35:476-494 Raphael KG et.al., JADA 2012;143:1223-1231 Klasser GD J Can Dent Assoc 2015;81:12 Monday, August 31, 15 Diurnal (Awake) Bruxism Prolonged (Up to 30+ min), Low-level Awake Tensing /Clenching of Jaw Causes Delayed Pain Than Brief Sleep Bruxism Events EMG Levels Specific Areas Depending on Jaw Position Management: Aware Oral Habits, Relaxation & Coping Strategies Palla S. 5th International Conference OFP &TMD Brazil 2009 Monday, August 31, 15 Sleep Bruxism Management • • • • • • • • • • Behavioral: Stress Management, Relaxation Strategies & Sleep Hygiene Pharmacological: Benzodiazepine (Clonazepam, Valium, Xanax, Ativan) Muscle Relaxants (Flexeril) Tricyclic Antidepressants (Pamelar, Doxepin) Anticonvulsants (Gabapentin) Botulinum Toxin Occlusal Splints/Nightguards?? Only if Symptoms worse on waking Protects excessive tooth wear Lobbezoo F., Orofacial Pain: From Basic Science to Clinical Management, Quintessence 2008 Monday, August 31, 15 TENDONITIS DEFINITION: Tendinous Inflammation 2° to Repetitive Strain, Direct Trauma or Injury CLINICAL PRESENTATION: • Acute Pain Initially • Extreme Tend. w Palpation • Increased Pain w Mand. Mvt. • Possible Limited ROM • Prolonged Recovery Typical Monday, August 31, 15 GOAL ORIENTED PLAN: Tendinitis v PAIN CONTROL: Immediate Goal v v v v DECREASED MOBILITY: v Monday, August 31, 15 Self-Management (Rest, Relax. Jaw, Ice) Meds (NSAIDs, Analgesics, Ms Relax.?) PT (Cold, ES, STM & US) Physical Therapy (Home Exercise Progressive Self-Mgt Program) Myospasm (Trismus) DEFINITION: Acute, Sudden, Involuntary, Tonic Contraction of a Muscle CLINICAL PRESENTATION: • Acute Onset of Pain • • • • • Monday, August 31, 15 Pain at Rest & w Function Continuous Involuntary Muscle Contraction Significant Decrease in Jaw Mobility & Fx. Increased EMG Activity at Rest May Be Assoc. w Myositis o Local Infection GOAL ORIENTED PLAN: Myospasm (Trismus) v PAIN CONTROL: v v v v Self-Management (Rest, Ice) Meds (Analgesics, Anxiolytics, Ms. Relax., Antiobiotics) Physical Therapy (ES, US, STM, Cold) INCREASE MOBILITY: v v Monday, August 31, 15 Physical Therapy (STM & Jt. Mob.) Home Ex. Prog. (A/A ROM & AROM Ex.) GOAL ORIENTED PLAN v v v Restore Normal Function: (Passive & Active – Assisted Exs.) Taper Meds Progressive Self-Mgt Program Monday, August 31, 15 GOAL ORIENTED PLAN v v v Restore Normal Function: (Passive & Active – Assisted Exs.) Taper Meds Progressive Self-Mgt Program Monday, August 31, 15 Acute Musculoskeletal TMD/OFP Management Model NIDCR Policy Statement 2013 Patient Education Symptomatic Care Behavior Modification Pharmacotherapy Physical Rehabilitation (Orthoses/Splints) Monday, August 31, 15 Acute Musculoskeletal TMD/OFP Management Model NIDCR Policy Statement 2013 Patient Education Symptomatic Care Behavior Modification Pharmacotherapy Physical Rehabilitation (Orthoses/Splints) Monday, August 31, 15 MANAGEMENT PHILOSOPHY Diagnostically Driven Problem-Based Goal Oriented Acute Musculoskeletal TMD/OFP Management Model NIDCR Policy Statement 2013 Patient Education Symptomatic Care MANAGEMENT PHILOSOPHY Diagnostically Driven Problem-Based Goal Oriented Behavior Modification MANAGEMENT GOALS Pharmacotherapy Physical Rehabilitation (Orthoses/Splints) Monday, August 31, 15 Relieve Pain Promote Healing Restore Functional ROM Optimize Masticatory Function Return to Previous Level of ADL Acute Musculoskeletal TMD/OFP Management Model NIDCR Policy Statement 2013 Patient Education Symptomatic Care Behavior Modification MANAGEMENT GOALS Pharmacotherapy Physical Rehabilitation (Orthoses/Splints) Monday, August 31, 15 Relieve Pain Promote Healing Restore Functional ROM Optimize Masticatory Function Return to Previous Level of ADL Acute Musculoskeletal TMD/OFP Management Model NIDCR Policy Statement 2013 Patient Education Symptomatic Care Behavior Modification Pharmacotherapy Physical Rehabilitation (Orthoses/Splints) Monday, August 31, 15 Acute Musculoskeletal TMD/OFP Management Model NIDCR Policy Statement 2013 Patient Education Symptomatic Care Behavior Modification Pharmacotherapy Physical Rehabilitation (Orthoses/Splints) Monday, August 31, 15 NO SURGERY or TREATMENT of the OCCLUSION Acute Musculoskeletal TMD/OFP Management Model NIDCR Policy Statement 2013 Patient Education Symptomatic Care Behavior Modification Pharmacotherapy Physical Rehabilitation (Orthoses/Splints) Monday, August 31, 15 NO SURGERY or TREATMENT of the OCCLUSION The thing about science is, even if you don’t believe in it, it’s still true. Neil deGrasse Tyson Monday, August 31, 15